Incidence and Predicting Factors for Abnormal Thyroid Function Test in Adult Patients Post Hematopoietic Stem Cell Transplantation at King Hussein Cancer Center
Journal Title: Journal of Endocrinology and Diabetes - Year 2016, Vol 3, Issue 4
Abstract
Introduction: The risk of abnormal thyroid function after hematopoietic stem cell transplantation (HSCT) is well-known especially in pediatric patients. There are few studies about adult patients that showed 3-year cumulative incidence ranges between 8-23%. In this study we studied the incidence of abnormal thyroid function in patients older than 18 years, and reviewed its predicting factors. Patients and Method: This is a retrospective study for all adult patients who underwent HSCT at KHCC from 2004-2010.Our cohort consisted of 108 patients who had normal thyroid function before transplant, and at least one Thyroid Function Test (TFT) done after transplant. From the group 54.8% had autologous transplant, 45.2% had allogenic transplant from which 94.6% had myeloablative transplant. Total Body Irradiation (TBI) was used in the conditioning regimen in 29% of the patients. Results: At a median follow up of 1.1 year (0.1-6.1 years), 34 patients (31%) developed abnormal thyroid function tests, high TSH accounted for 40.7%, low TSH for 38.9%, low T4 for 11.1%, and high TSH with low T4 for 3.7%. The factors that showed significant correlation with Abnormal Thyroid Function (ATF) were: Female gender, allogenic transplant, and TBI-based conditioning. From the 34 patients who developed abnormal test after transplant, 61.7% of them developed thyroid dysfunction in the first year post transplant, and 20.5% in the second year. Conclusion: The incidence of abnormal thyroid function for adult patients after HSCT is around 30%. Most of the abnormalities happened in the first 2 years after transplant. Female gender, allogenic transplant, and TBI-based conditioning were associated with more occurrences of thyroid function abnormalities.
Authors and Affiliations
Enas F Younis, Fawzi A. Abdel-Rahman, Ayad A. Hussein, Husam A. Abu-Jazar, Abdulhadi I. Al-Zaben, OmarZ. Al-Rawi, Adnan M. Saad, Nilly N. Hussein
Keywords
Related Articles
- EP ID EP333677
- DOI 10.15226/2374-6890/3/4/00155
- Views 104
- Downloads 0
Emotional Intelligence is Associated with Blood Level Glucose: A Brief Report
Preliminary evidence associate aspects of emotion regulation and effective management of emotion-driven behavior with health outcomes in general and diabetic outcomes in particular. This study examined this association i...
Pseudohypoaldosteronism in Two Omani Siblings with a Novel Mutation in the SCNN1A Gene
Background:Type1 PHA is a rare heterogeneous group of disorders with resistance to the action of Aldosterone. Biochemically, it is characterized by hyponatremia, hyperkalemia, metabolic acidosis and elevated serum Aldost...
3-Iodothyronamine: A High Potency Metabolic Hormone and its Potential for Therapeutic Applications
3-Iodothyronamide (T1AM) is a naturally produced endogenous hormone like molecule. Only recently it has been discovered in the past decade, the proceeding body of research emerging from its initial discovery has revealed...
Outcome of Patients with Diabetic Ketoacidosis in South of Iran
Introduction: Diabetic Keto acidosis (DKA) is the most common cause of mortality in children with diabetes mellitus. The aim of this study is to investigate the complications of DKA and its complications in hospitalized...
Favorable Effect of Bromocriptine and Pentoxifylline in Mild Graves Disease Orbitopathy: A Randomized, Open, Clinical Trial
Background:Graves’ orbitopathy (GO) is the most frequent extra thyroidal manifestation of Graves’ disease. Treatment for mild cases consists in euthyroidism restoration and topical treatments. Aim: To evaluate the effec...